N-Methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine

Catalog No. :
ACMNDN308
CAS No. :
642075-19-2
Molecular Formula :
C6H11N3
Molecular Weight :
125.18

IUPAC Name:N-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine

N-Methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$149.00Login to see priceInquiryInquiry
100mg95%$215.00Login to see priceInquiryInquiry
250mg95%$299.00Login to see priceInquiryInquiry
1g95%$703.00Login to see priceInquiryInquiry
5g95%$2000.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine
IUPAC NameN-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine
MDL No.MFCD05864571
Molecular FormulaC6H11N3
Molecular Weight125.18
SMILESCN1C=CN=C1CNC
InChI KeyYFSZWZHEKIMAJJ-UHFFFAOYSA-N
SynonymMETHYL-(1-METHYL-1H-IMIDAZOL-2-YLMETHYL)-AMINE;1H-Imidazole-2-methanamine,N,1-dimethyl-(9CI);N-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine(SALTDATA: 2HCl);N-Methyl-N-[(1-methyl-1H-imidazol-2-yl)methyl]amine;N-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine;1H-Imidazole-2-methanamine, N,1-dimethyl-;N,1-Dimethyl-1H-imidazole-2-methanamine
CAS No.642075-19-2

Synthetic Route by SureRoute

1. ACMNDN308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOEC406 route compound structure diagram
    ACPOEC40613750-81-7 In Stock
  4. Then
  5. ACMNDN308 route product structure diagram
    ACMNDN308642075-19-2
Inquiry

2. ACMNDN308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGCMZ416 route compound structure diagram
    ACGCMZ41678667-04-6 In Stock
  4. Then
  5. ACMNDN308 route product structure diagram
    ACMNDN308642075-19-2
Inquiry

Comments (0)